https://funtrafoo.com/daily-feeds/glenmarks-interim-data-from-pms-study-on-favipiravir-fabiflu-supports-its-safety-and-effectiveness-in-real-world-settings-with-no-new-safety-signals-or-concerns-in-covid-19-patients/15771/
Glenmark’s interim data from PMS Study on Favipiravir (FabiFlu®) supports its safety and effectiveness in real world settings with no new safety signals or concerns in Covid-19 patients